RPRX
Royalty Pharma plc · Healthcare
EVP, Research, Investments Marshall Urist sold $786K of Royalty Pharma plc
Sold$786,380
$39.32Price
20,000Shares
−14%Stake
What RPRX did after the filing
- The stock from Tue, Dec 30 open, $38.66
- +14.8%
- S&P 500, same days
- −0.9%
Measured over 30 trading days, to the Feb 12 close.
Traded Fri, Dec 26. Filed Mon, Dec 29, 4:58 PM ET, after the close. Returns use the Dec 30 open and the Feb 12 close. Not investment advice.